Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Hemodynamic Stability in Hypertensive Laparoscopic Cholecystectomy
NCT04646317Phase 1Unknown
- Sponsor
- Dr. Ruth K.M. Pfau Civil Hospital Karachi
- Start
- Dec 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of dexmedetomidine in hypertension (HTN) (2 arms), sponsored by Dr. Ruth K.M. Pfau Civil Hospital Karachi. Primary endpoints: Change in Systolic Blood Pressure, Change in Diastolic Blood Pressure and 2 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04646317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04646317.